Literature DB >> 29520572

Assessment of left ventricular ejection fraction with cardiofocal collimators: Comparison between IQ-SPECT, planar equilibrium radionuclide angiography, and cardiac magnetic resonance.

Matthieu Pelletier-Galarneau1, Vincent Finnerty2, Stephanie Tan2, Sebastien Authier2, Jean Gregoire2, Francois Harel2.   

Abstract

BACKGROUND: IQ-SPECT has been shown to significantly reduce acquisition time and administered dose while preserving image quality in myocardial perfusion imaging. Whether IQ-SPECT provides accurate left ventricular ejection fractions (LVEF) with gated blood pool SPECT (GBPS) remains unknown.
METHODS: Sixty patients underwent IQ-SPECT GBPS and planar imaging. Among those patients, 11 underwent both cMRI and GBPS. GBPS LVEF, LVEDV, and LVESV were calculated using 2 validated software; QBS (Cedars-Sinai Medical Center, Los Angeles, USA) and MHI (Montreal Heart Institute, Montreal, Canada). LVEF, LVEDV, and LVESV obtained with the different modalities were compared.
RESULTS: Average planar LVEF was 48 ± 11% (mean ± SD), average LVEDV was 177 ± 59 mL (range 63 to 342 mL), and average LVESV was 96 ± 46 mL (range 16 to 234 mL). GBPS LVEF and their correlation coefficient with planar LVEF were 40 ± 12% (r = 0.70) and 44 ± 12% (r = 0.83) with QBS and MHI, respectively. Correlation coefficient between cMRI and planar LVEF was 0.65 and were 0.69 and 0.52 between cMRI and GBPS using QBS and MHI, respectively.
CONCLUSIONS: LVEF calculated with GBPS using IQ-SPECT correlates with planar measurements. Correlation is best using the MHI method and variation is independent of LVEDV.

Entities:  

Keywords:  Collimation; Gated blood pool imaging; Left ventricular function; Radionuclide angiography

Mesh:

Year:  2018        PMID: 29520572     DOI: 10.1007/s12350-018-1251-6

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  4 in total

1.  Procedure guideline for equilibrium radionuclide ventriculography. Society of Nuclear Medicine.

Authors:  M D Wittry; J E Juni; H D Royal; G V Heller; S C Port
Journal:  J Nucl Med       Date:  1997-10       Impact factor: 10.057

2.  Diagnostic accuracy and functional parameters of myocardial perfusion scintigraphy using accelerated cardiac acquisition with IQ SPECT technique in comparison to conventional imaging.

Authors:  Christian Pirich; Peter Keinrath; Gabriele Barth; Gundula Rendl; Lukas Rettenbacher; Margarida Rodrigues
Journal:  Q J Nucl Med Mol Imaging       Date:  2014-06-30       Impact factor: 2.346

3.  Quantification of three-dimensional left ventricular segmental wall motion and volumes from gated tomographic radionuclide ventriculograms.

Authors:  T L Faber; E M Stokely; G H Templeton; M S Akers; R W Parkey; J R Corbett
Journal:  J Nucl Med       Date:  1989-05       Impact factor: 10.057

4.  Phase dyssynchrony and 123I-meta-iodobenzylguanidine innervation imaging towards standardization.

Authors:  Kenichi Nakajima; Koichi Okuda; Hein J Verberne
Journal:  J Nucl Cardiol       Date:  2017-09-18       Impact factor: 5.952

  4 in total
  3 in total

1.  Applying a correction factor to gated blood pool SPECT left ejection fraction value: Can this approach be used to get around a longstanding hurdle?

Authors:  Sylvain Prévost; Etienne Rousseau
Journal:  J Nucl Cardiol       Date:  2019-03-04       Impact factor: 5.952

2.  Low-dose dobutamine stress gated blood pool SPECT assessment of left ventricular contractile reserve in ischemic cardiomyopathy: a feasibility study.

Authors:  Vladimir V Shipulin; Sergey L Andreev; Andrew S Pryakhin; Andrew V Mochula; Alina N Maltseva; Svetlana I Sazonova; Vladimir M Shipulin; Samia Massalha; Konstantin V Zavadovsky
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-02-12       Impact factor: 10.057

3.  In vivo positron emission tomographic blood pool imaging in an immunodeficient mouse model using 18F-fluorodeoxyglucose labeled human erythrocytes.

Authors:  Jung W Choi; Mikalai Budzevich; Shaowei Wang; Kenneth Gage; Veronica Estrella; Robert J Gillies
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.